Literature DB >> 25008979

The impact of physical impairment on emotional well-being in ALS.

Susanne Abdulla1, Stefan Vielhaber, Katja Kollewe, Judith Machts, Hans-Jochen Heinze, Reinhard Dengler, Susanne Petri.   

Abstract

There has been evidence that subjective quality of life in patients with amyotrophic lateral sclerosis (ALS) is comparatively good, unrelated to the state of physical functioning, so called 'disability paradox'. Other studies show weak to moderate correlations between disease severity and emotional well-being. Our aim was to analyse the impact of physical impairment on emotional well-being when assessed disease-specifically and seen through the patient's eyes with additional clinical evaluation. In 121 patients emotional functioning was evaluated by the ALS Assessment Questionnaire (ALSAQ-40). Physical status was assessed by the ALS Functional Rating Scale-Extension (ALSFRS-EX) and Borg dyspnoea scales and by clinical examination (muscle strength and pulmonary function). Multiple regression and correlation analyses were performed. Results showed that physical impairment and progression rate of physical deterioration had a significant impact and explained some variance in emotional well-being (adjusted R(2) = 0.22). Pulmonary function and the sense of dyspnoea correlated significantly on a weak to moderate level with emotional well-being. In conclusion, disease-specific patient- reported outcome measurement instruments revealed a moderate but distinct impact of physical impairment on emotional well-being. This study challenges the 'disability paradox' and has relevant findings that can support the timely delivery of care for ALS patients.

Entities:  

Keywords:  ALSAQ-40; Amyotrophic lateral sclerosis; emotional well-being; functional rating scale; patient-reported outcome measure

Mesh:

Year:  2014        PMID: 25008979     DOI: 10.3109/21678421.2014.932380

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  5 in total

1.  Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis.

Authors:  Riccardo Marvulli; Marisa Megna; Aurora Citraro; Ester Vacca; Marina Napolitano; Giulia Gallo; Pietro Fiore; Giancarlo Ianieri
Journal:  Toxins (Basel)       Date:  2019-07-01       Impact factor: 4.546

2.  Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data.

Authors:  Tino Prell; Nayana Gaur; Robert Steinbach; Otto W Witte; Julian Grosskreutz
Journal:  Health Qual Life Outcomes       Date:  2020-05-01       Impact factor: 3.186

3.  Pain-Related Coping Behavior in ALS: The Interplay between Maladaptive Coping, the Patient's Affective State and Pain.

Authors:  Ina Schlichte; Susanne Petri; Reinhard Dengler; Thomas Meyer; Aiden Haghikia; Stefan Vielhaber; Susanne Vogt
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

4.  Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis.

Authors:  Shelagh K Genuis; Westerly Luth; Tania Bubela; Wendy S Johnston
Journal:  BMC Neurol       Date:  2022-04-12       Impact factor: 2.474

5.  Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Agnieszka Meller; Karolina Machowska-Sempruch; Agnieszka Wełnicka; Edyta Paczkowska; Iwona Rotter; Bogusław Machaliński; Przemysław Nowacki
Journal:  BMC Neurol       Date:  2019-10-19       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.